Shih-Hua Lin Selected Research

U 74500A

8/2004

Protective effect of U74500A on phorbol myristate acetate-induced acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shih-Hua Lin Research Topics

Disease

29	Hypokalemia 03/2021 - 05/2002
21	Paralysis (Palsy) 03/2021 - 03/2002
17	Acidosis 01/2022 - 11/2002
16	Hypertension (High Blood Pressure) 01/2022 - 05/2002
16	Gitelman Syndrome 01/2021 - 05/2003
15	Alkalosis 03/2021 - 05/2002
12	Hyperkalemia 01/2022 - 10/2003
12	Proteinuria 01/2021 - 07/2008
11	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 09/2005
10	Hyponatremia 01/2020 - 05/2002
9	Chronic Renal Insufficiency 01/2022 - 04/2006
9	Renal Insufficiency (Renal Failure) 12/2013 - 03/2002
8	Inflammation (Inflammations) 12/2020 - 06/2011
7	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2017 - 09/2003
7	Bartter Syndrome (Syndrome, Bartter) 01/2017 - 05/2005
7	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 05/2014 - 01/2003
6	Hyperthyroidism 11/2021 - 01/2003
6	Hypotension (Low Blood Pressure) 11/2020 - 05/2003
6	Hypercalciuria 02/2014 - 01/2005
6	Hypophosphatemia 08/2012 - 07/2003
5	Infections 01/2022 - 12/2013
5	Secondary Hyperparathyroidism 10/2013 - 12/2003
4	Pseudohypoaldosteronism 01/2022 - 10/2009
4	Uremia 09/2021 - 02/2013
4	Ischemic Stroke 01/2019 - 07/2015
4	Hypercalcemia (Milk Alkali Syndrome) 04/2015 - 12/2003
4	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2015 - 11/2004
4	Insulin Resistance 01/2013 - 10/2003
4	Muscle Weakness 01/2009 - 01/2003
3	Peritonitis 09/2021 - 09/2007
3	Vascular Calcification 06/2021 - 02/2012
3	Hemorrhage 01/2021 - 12/2009
3	Arteriovenous Fistula 01/2020 - 12/2013
3	Anorexia 01/2017 - 01/2013
3	Lung Injury 10/2015 - 07/2005
3	Fibrosis (Cirrhosis) 08/2015 - 06/2011
3	Body Weight (Weight, Body) 05/2015 - 10/2003
3	Hyperaldosteronism (Conn Syndrome) 03/2015 - 09/2003
3	Neoplasms (Cancer) 01/2015 - 05/2006
3	Vomiting 02/2014 - 05/2006
3	Glomerulonephritis 08/2013 - 11/2004
3	Nephrocalcinosis 03/2013 - 02/2009

Drug/Important Bio-Agent (IBA)

26	PotassiumIBA 01/2022 - 05/2002
17	CalciumIBA 11/2018 - 05/2002
14	CreatinineIBA 01/2021 - 03/2002
11	Proteins (Proteins, Gene)FDA Link 06/2021 - 11/2002
10	SaltsIBA 01/2020 - 05/2002
10	Phosphotransferases (Kinase)IBA 01/2019 - 10/2009
9	AcidsIBA 03/2021 - 10/2003
9	DiureticsIBA 01/2017 - 09/2003
8	Phosphates (Orthophosphate)IBA 06/2021 - 05/2002
8	SodiumIBA 01/2021 - 09/2008
8	Insulin (Novolin)FDA Link 01/2015 - 10/2003
7	ElectrolytesIBA 01/2022 - 01/2003
7	ReninIBA 01/2022 - 12/2007
7	SteroidsIBA 09/2021 - 05/2006
7	AldosteroneIBA 01/2020 - 12/2007
7	Parathyroid Hormone (Parathormone)IBA 11/2018 - 10/2003
7	Potassium Chloride FDA LinkGeneric 09/2015 - 10/2003
5	ThiazidesIBA 01/2022 - 09/2003
5	Hormones (Hormone)IBA 11/2021 - 11/2004
5	Bumetanide (Bumex)FDA LinkGeneric 01/2020 - 11/2010
5	Alanine (L-Alanine)FDA Link 01/2019 - 11/2010
5	ChloridesIBA 01/2019 - 06/2010
5	Proline (L-Proline)FDA Link 01/2019 - 11/2010
5	Saline SolutionIBA 03/2015 - 05/2002
5	Member 3 Solute Carrier Family 12IBA 01/2015 - 02/2004
5	MineralocorticoidsIBA 09/2013 - 03/2004
5	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 04/2012 - 07/2003
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
4	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2020 - 03/2004
4	Complement System Proteins (Complement)IBA 01/2020 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 11/2004
4	Lysine (L-Lysine)FDA Link 08/2017 - 01/2013
4	CytokinesIBA 10/2016 - 02/2004
4	Bronchodilator Agents (Bronchodilators)IBA 09/2014 - 03/2004
4	C-Reactive ProteinIBA 01/2014 - 04/2006
4	Antigen-Antibody Complex (Immune Complex)IBA 02/2012 - 11/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 10/2003
3	Hemoglobins (Hemoglobin)IBA 11/2020 - 10/2003
3	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2012
3	LipidsIBA 10/2019 - 10/2003
3	Sodium-Potassium-Chloride SymportersIBA 01/2019 - 07/2015
3	AlbuminsIBA 09/2018 - 08/2006
3	Urea (Carbamide)FDA LinkGeneric 09/2018 - 11/2005
3	Cholecalciferol (Vitamin D3)FDA Link 11/2017 - 09/2005
3	AntigensIBA 05/2016 - 09/2003
3	Glucose (Dextrose)FDA LinkGeneric 07/2015 - 02/2013
3	GlucocorticoidsIBA 04/2015 - 05/2006
3	Therapeutic UsesIBA 02/2014 - 12/2009
3	Chloride Channels (Chloride Channel)IBA 02/2014 - 05/2005

Therapy/Procedure

37	Therapeutics 09/2021 - 05/2002
16	Renal Dialysis (Hemodialysis) 12/2017 - 05/2003
7	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2021 - 10/2003
6	Peritoneal Dialysis 12/2017 - 07/2011
3	Blood Transfusion (Blood Transfusions) 01/2020 - 01/2010
3	Nephrectomy 01/2019 - 02/2013
3	Drug Therapy (Chemotherapy) 11/2018 - 05/2006
3	Catheters 12/2017 - 09/2007
3	Parathyroidectomy 09/2014 - 02/2009